Endothelial transcriptomics reveals activation of fibrosis-related pathways in hypertension

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hypertension poses a significant challenge to vasculature homeostasis and stands as the most common cardiovascular disease in the world. Its effects are especially profound on endothelial cells that form the inner lining of the vasculature and are directly exposed to the effects of excess pressure. Here, we characterize the in vivo transcriptomic response of cardiac endothelial cells to hypertension by rapidly isolating these cells from the spontaneous hypertension mouse model BPH/2J and its normotensive BPN/3J control strain and performing and RNA sequencing on both. Comparison of transcriptional differences between these groups reveals statistically significant changes in cellular pathways consistent with cardiac fibrosis found in hypertensive animals. Importantly, many of the fibrosis-linked genes identified also differ significantly between juvenile prehypertensive and adult hypertensive BPH/2J mice, suggesting that these transcriptional differences are hypertension related. We examined the dynamic nature of these transcriptional changes by testing whether blood pressure normalization using either a calcium channel blocker (amlodipine) or a angiotensin II receptor blocker (losartan) is able to reverse these expression patterns associated with hypertension. We find that blood pressure reduction is capable of reversing some gene-expression patterns, while other transcripts are recalcitrant to therapeutic intervention. This illuminates the possibility that unmanaged hypertension may irreversibly alter some endothelial transcriptional patterns despite later intervention. This study quantifies how endothelial cells are remodeled at the molecular level in cardiovascular pathology and advances our understanding of the transcriptional events associated with endothelial response to hypertensive challenge.

Original languageEnglish (US)
Pages (from-to)104-116
Number of pages13
JournalPhysiological Genomics
Volume50
Issue number2
DOIs
StatePublished - Feb 1 2018

Fingerprint

Fibrosis
Hypertension
Endothelial Cells
Blood Pressure
RNA Sequence Analysis
Amlodipine
Losartan
Angiotensin Receptor Antagonists
Calcium Channel Blockers
Homeostasis
Cardiovascular Diseases
Pathology
Gene Expression
Pressure
Genes
Therapeutics

Keywords

  • Cardiac
  • Endothelial
  • Hypertension
  • RNA-seq
  • Transcriptome

ASJC Scopus subject areas

  • Physiology
  • Genetics

Cite this

Endothelial transcriptomics reveals activation of fibrosis-related pathways in hypertension. / Nelson, Jonathan W.; Ferdaus, Mohammed Z.; McCormick, James (Jim); Minnier, Jessica; Kaul, Sanjiv; Ellison, David; Barnes, Anthony.

In: Physiological Genomics, Vol. 50, No. 2, 01.02.2018, p. 104-116.

Research output: Contribution to journalArticle

@article{e3c8b834a6024e208e32c99b73a51315,
title = "Endothelial transcriptomics reveals activation of fibrosis-related pathways in hypertension",
abstract = "Hypertension poses a significant challenge to vasculature homeostasis and stands as the most common cardiovascular disease in the world. Its effects are especially profound on endothelial cells that form the inner lining of the vasculature and are directly exposed to the effects of excess pressure. Here, we characterize the in vivo transcriptomic response of cardiac endothelial cells to hypertension by rapidly isolating these cells from the spontaneous hypertension mouse model BPH/2J and its normotensive BPN/3J control strain and performing and RNA sequencing on both. Comparison of transcriptional differences between these groups reveals statistically significant changes in cellular pathways consistent with cardiac fibrosis found in hypertensive animals. Importantly, many of the fibrosis-linked genes identified also differ significantly between juvenile prehypertensive and adult hypertensive BPH/2J mice, suggesting that these transcriptional differences are hypertension related. We examined the dynamic nature of these transcriptional changes by testing whether blood pressure normalization using either a calcium channel blocker (amlodipine) or a angiotensin II receptor blocker (losartan) is able to reverse these expression patterns associated with hypertension. We find that blood pressure reduction is capable of reversing some gene-expression patterns, while other transcripts are recalcitrant to therapeutic intervention. This illuminates the possibility that unmanaged hypertension may irreversibly alter some endothelial transcriptional patterns despite later intervention. This study quantifies how endothelial cells are remodeled at the molecular level in cardiovascular pathology and advances our understanding of the transcriptional events associated with endothelial response to hypertensive challenge.",
keywords = "Cardiac, Endothelial, Hypertension, RNA-seq, Transcriptome",
author = "Nelson, {Jonathan W.} and Ferdaus, {Mohammed Z.} and McCormick, {James (Jim)} and Jessica Minnier and Sanjiv Kaul and David Ellison and Anthony Barnes",
year = "2018",
month = "2",
day = "1",
doi = "10.1152/physiolgenomics.00111.2017",
language = "English (US)",
volume = "50",
pages = "104--116",
journal = "Physiological Genomics",
issn = "1094-8341",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - Endothelial transcriptomics reveals activation of fibrosis-related pathways in hypertension

AU - Nelson, Jonathan W.

AU - Ferdaus, Mohammed Z.

AU - McCormick, James (Jim)

AU - Minnier, Jessica

AU - Kaul, Sanjiv

AU - Ellison, David

AU - Barnes, Anthony

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Hypertension poses a significant challenge to vasculature homeostasis and stands as the most common cardiovascular disease in the world. Its effects are especially profound on endothelial cells that form the inner lining of the vasculature and are directly exposed to the effects of excess pressure. Here, we characterize the in vivo transcriptomic response of cardiac endothelial cells to hypertension by rapidly isolating these cells from the spontaneous hypertension mouse model BPH/2J and its normotensive BPN/3J control strain and performing and RNA sequencing on both. Comparison of transcriptional differences between these groups reveals statistically significant changes in cellular pathways consistent with cardiac fibrosis found in hypertensive animals. Importantly, many of the fibrosis-linked genes identified also differ significantly between juvenile prehypertensive and adult hypertensive BPH/2J mice, suggesting that these transcriptional differences are hypertension related. We examined the dynamic nature of these transcriptional changes by testing whether blood pressure normalization using either a calcium channel blocker (amlodipine) or a angiotensin II receptor blocker (losartan) is able to reverse these expression patterns associated with hypertension. We find that blood pressure reduction is capable of reversing some gene-expression patterns, while other transcripts are recalcitrant to therapeutic intervention. This illuminates the possibility that unmanaged hypertension may irreversibly alter some endothelial transcriptional patterns despite later intervention. This study quantifies how endothelial cells are remodeled at the molecular level in cardiovascular pathology and advances our understanding of the transcriptional events associated with endothelial response to hypertensive challenge.

AB - Hypertension poses a significant challenge to vasculature homeostasis and stands as the most common cardiovascular disease in the world. Its effects are especially profound on endothelial cells that form the inner lining of the vasculature and are directly exposed to the effects of excess pressure. Here, we characterize the in vivo transcriptomic response of cardiac endothelial cells to hypertension by rapidly isolating these cells from the spontaneous hypertension mouse model BPH/2J and its normotensive BPN/3J control strain and performing and RNA sequencing on both. Comparison of transcriptional differences between these groups reveals statistically significant changes in cellular pathways consistent with cardiac fibrosis found in hypertensive animals. Importantly, many of the fibrosis-linked genes identified also differ significantly between juvenile prehypertensive and adult hypertensive BPH/2J mice, suggesting that these transcriptional differences are hypertension related. We examined the dynamic nature of these transcriptional changes by testing whether blood pressure normalization using either a calcium channel blocker (amlodipine) or a angiotensin II receptor blocker (losartan) is able to reverse these expression patterns associated with hypertension. We find that blood pressure reduction is capable of reversing some gene-expression patterns, while other transcripts are recalcitrant to therapeutic intervention. This illuminates the possibility that unmanaged hypertension may irreversibly alter some endothelial transcriptional patterns despite later intervention. This study quantifies how endothelial cells are remodeled at the molecular level in cardiovascular pathology and advances our understanding of the transcriptional events associated with endothelial response to hypertensive challenge.

KW - Cardiac

KW - Endothelial

KW - Hypertension

KW - RNA-seq

KW - Transcriptome

UR - http://www.scopus.com/inward/record.url?scp=85043588932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043588932&partnerID=8YFLogxK

U2 - 10.1152/physiolgenomics.00111.2017

DO - 10.1152/physiolgenomics.00111.2017

M3 - Article

VL - 50

SP - 104

EP - 116

JO - Physiological Genomics

JF - Physiological Genomics

SN - 1094-8341

IS - 2

ER -